about
111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumorsA transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptakeBiokinetics of 111In-DTPA-D-Phe(1)-octreotide in nude mice transplanted with a human carcinoid tumor.Histamine metabolism of gastric carcinoids in Mastomys natalensis.Spring-assisted surgery in the treatment of sagittal synostosis: A systematic review.Gastroduodenal endocrine tumours.Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroidNESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.The relevance of somatostatin receptors in thyroid neoplasiaIn Vivo Chondrogenesis in 3D Bioprinted Human Cell-laden Hydrogel Constructs.Multicolor spectral karyotype analysis of a transplantable human ileal carcinoid.A retrospective review of the incidence of various complications in different delayed breast reconstruction methods.Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.Long-Term Health-Related Quality of Life after Breast Reconstruction: Comparing 4 Different Methods of Reconstruction.Blood loss and duration of surgery are independent risk factors for complications after breast reconstruction.Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors.Effects of treatment with (177)Lu-DOTA-Tyr(3)-octreotate on uptake of subsequent injection in carcinoid-bearing nude mice.A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis.Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice.Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.Biodistribution and dosimetry of 177Lu-labeled [DOTA0,Tyr3]octreotate in male nude mice with human small cell lung cancer.Intraocular transplantation and primary cell cultures as experimental models for the study of human carcinoid disease.A new method to estimate parameters of the growth model for metastatic tumours.Patient determinants as independent risk factors for postoperative complications of breast reconstruction.Conservative Healing of an 11 × 9-cm Aplasia Cutis Congenita of the Scalp with Bone DefectA randomized prospective study of prophylactic cloxacillin in breast reduction surgery.Intracranial volume in 15 children with bilateral coronal craniosynostosis.Expression of cholecystokinin-B/gastrin receptors in medullary thyroid cancer.[177Lu-DOTA 0-Tyr 3]-octreotate treatment in patients with disseminated gastroenteropancreatic neuroendocrine tumors: the value of measuring absorbed dose to the kidney.Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour.Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.Correction of hypotelorism in isolated metopic synostosis.Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration.New objective measurement of forehead symmetry in unicoronal craniosynostosis - comparison between fronto-orbital advancement and forehead remodelling with a bone graft.GOT1 xenografted to nude mice: a unique model for in vivo studies on SSTR-mediated radiation therapy of carcinoid tumors.Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.Chromogranin A as a determinant of midgut carcinoid tumour volume.Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.
P50
Q28142091-70FBC2D2-BEE7-4A9A-BAFA-924ED4792EF5Q28346172-8575480B-CF49-4F65-810E-6540ABAA15DFQ31970580-1ABD4C0A-1450-4204-AD50-84681EBE549EQ33719553-FBDBDFB8-B6E1-429E-89E8-08946EACA964Q35560095-34D190B0-5B83-40A2-A598-EADE4B930755Q36013642-2C8BB42F-5852-467E-943C-3FB88F464E66Q36291710-AD27D3B5-ABD7-42D2-B825-F9A89DC3DEE2Q36619169-DFC0AE10-36E5-4C2C-88D6-3D1DBDBBEA74Q36648990-EF0706EE-DA10-4877-943E-0BFAF3145445Q36988027-8CF410B9-4675-4B75-871E-CBD2FB83179BQ37684953-75B0DAB9-84FC-4D4B-9D0E-99A87323FEBBQ38495195-330AF17C-2A0C-4507-81E1-C8667999DB52Q38584823-9BE4F5F5-91A9-4428-B1C8-EC5A7A6A0E63Q38602413-B403FB6B-2010-46CE-B86A-A7107E81DE06Q38663250-76C9810B-8944-44B6-8551-75039BDE47E0Q38999302-44A09279-3F40-4C7B-93B6-9147AB73F9BEQ39448203-BE7D1F99-AE40-42D1-B31E-72555926B46FQ40057720-10FB0FCB-D282-428A-BDDF-854EC756A299Q40105303-B4619218-038C-4F4E-ABBF-C61ACC357601Q40208917-D6694D32-043D-4317-BA18-68A3657F02CAQ40310196-23D55D05-B55C-46E4-9201-489682319FFDQ40427340-F9AD8D05-C333-4924-BEA4-8DC5B571CA53Q40632551-EDC97CEE-8FE8-404E-82AA-507CD36B45CBQ40642508-F6CE878A-61FD-4AD3-BC8D-42B22DC11077Q41025334-E0FA9F07-F687-4150-BEC3-ECA6FDA053F5Q41485604-84E55648-688D-45C1-883E-42E568D80B10Q41611215-FB463A4D-8505-4181-B3D8-3B3288503D49Q41705630-E2DE48DC-26C4-4A21-B3CF-5D2504265432Q42003929-9220E98F-178A-4843-A8FB-C8C4FD8F96C8Q42608082-E0FE6CEC-9B77-4A4A-B6F5-80326D2B9B8FQ43196885-F0412AEC-F199-4DE7-9D5E-9E3AF1F9C3B4Q43200565-F66E9B97-D2E0-4ACC-8736-211FC3EAA6ECQ43824680-CD6315E4-8FFD-464E-8E90-6896A032C0C1Q44290639-EF6DF675-AFBD-4B35-AFEF-F28DEDE2A3B9Q44439642-A5F2C9B6-D94D-4FD5-85A6-0C7A76764BCBQ44785369-18F55A32-CCF9-4C4C-9150-788856839328Q44903225-965B8ADA-1D60-49E2-B2AC-A2EDCA337187Q44903228-B1030CDA-3A93-4815-AE7D-D02E9810B702Q44921540-EC777A4D-1A1C-48E6-A388-DCF6113BC885Q46055528-1636D89A-6FCC-4FB5-A8FF-CE8BFAD4192D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lars Kölby
@ast
Lars Kölby
@en
Lars Kölby
@es
Lars Kölby
@nl
Lars Kölby
@sl
type
label
Lars Kölby
@ast
Lars Kölby
@en
Lars Kölby
@es
Lars Kölby
@nl
Lars Kölby
@sl
prefLabel
Lars Kölby
@ast
Lars Kölby
@en
Lars Kölby
@es
Lars Kölby
@nl
Lars Kölby
@sl
P106
P31
P496
0000-0001-9808-5935